This treatment defines a potent mixture of three viral agents used to manage Human Immunodeficiency Virus . Specifically , it comprises bichigravirs , emtricitabine , and tenofovir alafenamide . Bichigravirs inhibits by interfering with the enzyme of HIV, which is essential for the virus's ability to copy itself . The emtricitabine component also